Indivior Pharmaceuticals INDV
NASDAQ INDV
$35.71 +0.33 (+0.93%)
At close: Oct 2, 2026 · 4:00 PM EDT

Indivior Pharmaceuticals (INDV) Return on Assets [ROA] (2025 - 2026)

Updated

Indivior Pharmaceuticals (INDV) recorded Return on Assets [ROA] of 29.22% in Q2 2026, up 21.51 percentage points from 7.71% a year earlier and up 8.28 percentage points from the prior quarter.

Analysis

Indivior Pharmaceuticals (INDV) Return on Assets [ROA] (2025 - 2026) Analysis & Trends

For FY2025, Indivior Pharmaceuticals reported Return on Assets [ROA] of 16.69%, up 16.23 percentage points from FY2024.

  • Across earlier years, Return on Assets [ROA] came in at 0.46% in FY2024.
  • Per Business Quant, the preceding three quarters came in at 20.93% (Q1 2026), 16.05% (Q4 2025) and 9.00% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 10.47%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.65%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.45%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 28.37%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.10%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 9.29%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -6.13%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.14%
10 Indivior Pharmaceuticals 4.21 Bn 3.18 Bn 294.00 Mn 29.22%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 29.22%
Mar 31, 2026 20.93%
Dec 31, 2025 16.05%
Sep 30, 2025 9.00%
Jun 30, 2025 7.71%
Mar 31, 2025 -0.52%
API Access

Indivior Pharmaceuticals Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=INDV&period=max&api_key=YOUR_API_KEY